Manipal Health Enterprises IPO lists at 11% premium, signaling strong investor appetite

The healthcare operator's shares opened at ₹655 on the BSE, well above the ₹590 issue price, validating the valuation set for its public debut.

By Handelsavisen Newsroom · Automated 5 August 2026, 04:36 UTC · 1 min read Last updated: 5 August 2026, 05:07 UTC

PreviousArdee Industries IPO opens at ₹50-53 price band after strong anchor support →

LIVE

Prepublish Dedup Update · updated 5 August 2026, 04:36 UTCThis story updates earlier coverage: Ardee Industries IPO opens at ₹50-53 price band after strong anchor support

Part of newsroom saga · Other

Tech Market Volatility

LIVE

Manipal Health Enterprises shares surged on their market debut, listing at an 11% premium to the issue price on the Bombay Stock Exchange.

The Bengaluru-based healthcare operator opened trading at ₹655 per share, significantly outperforming the ₹590 price cap set for its initial public offering.

The strong opening reflects robust demand from investors and validates the valuation framework established during the pricing phase.

The stock's performance underscores the market's confidence in the company's growth prospects and operational scale.

By listing well above the upper end of the ₹560-₹590 price band, the shares delivered immediate returns for IPO allottees.

The premium indicates that institutional and retail investors alike view the healthcare sector as a resilient investment theme, even amid broader market volatility.